Overview & Formulation

CartiNet-G is a targeted therapeutic combination of Diacerein and Glucosamine presented in Alu-Alu blister packaging. Specifically created for chronic joint disorders, it combines slow-acting symptomatic relief with structural disease-modifying capabilities for articular cartilage.

Mechanism & Synergy

Diacerein inhibits Interleukin-1 beta (IL-1β), a major pro-inflammatory cytokine responsible for cartilage degradation and synovial inflammation in joint diseases. Simultaneously, Glucosamine serves as a vital biochemical precursor for glycosaminoglycans and proteoglycans, facilitating active repair and regeneration of damaged articular cartilage matrix.

Key Benefits & Applications

CartiNet-G helps slow down joint space narrowing, alleviates persistent joint pain, and improves overall structural functionality in patients suffering from mild-to-moderate osteoarthritis. Its dual-action approach targets both the inflammatory cascade and the underlying structural breakdown.

Quality & Usage

Packaged in premium Alu-Alu strips to guard against ambient moisture and degradation, CartiNet-G is manufactured to deliver consistent therapeutic outcomes when taken as part of a prescribed orthopaedic management plan.